Document Detail

Beta-blocker therapy in heart failure.
MedLine Citation:
PMID:  11407109     Owner:  NLM     Status:  MEDLINE    
beta-blocker therapy in heart failure offers the possibility of arresting or reversing the progressive deterioration in this clinical syndrome. While the mechanism is unclear, improvement in cardiac function has been apparent in virtually every study. Clinical results have shown less consistent improvement. Decrease in hospitalization has been noted, but large-scale clinical trials are underway to assess the effect of beta-blockers on mortality.
P Carson
Related Documents :
21604919 - Endothelial dysfunction predicts clinical restenosis after percutaneous coronary interv...
22221949 - Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in...
21624549 - Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis...
22848809 - Comparative analysis between spect myocardial perfusion imaging and ct coronary angiogr...
9679719 - Heterogeneous expression and activity of endothelial and inducible nitric oxide synthas...
21872559 - Myocardial performance is reduced immediately prior to ventricular ectopy.
17186979 - Different effect of the pure na+ channel-blocker pilsicainide on the st-segment respons...
3157309 - Electrocardiogram, clinical findings and chest x-ray in persons aged 85 years or older.
18310509 - Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardi...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology clinics     Volume:  19     ISSN:  0733-8651     ISO Abbreviation:  Cardiol Clin     Publication Date:  2001 May 
Date Detail:
Created Date:  2001-06-15     Completed Date:  2001-10-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  267-78, vi     Citation Subset:  IM    
Department of Veterans Affairs Medical Center, Georgetown University Hospital, Washington, District of Columbia, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / pharmacology,  therapeutic use*
Exercise Test / drug effects
Heart Failure / drug therapy*,  mortality,  physiopathology
Heart Rate / drug effects
Hemodynamics / drug effects
Myocardial Contraction / drug effects
Stroke Volume / drug effects
Sympathetic Nervous System / physiopathology
Ventricular Remodeling / drug effects
Reg. No./Substance:
0/Adrenergic beta-Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
Next Document:  Update in pharmacologic treatment of hypertension.